Monte Rosa Therapeutics, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5
Rok finansowy 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 76
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% 0.0% inf%
Marża brutto -inf% -inf% -inf% -inf% -inf% 100.0%
EBIT (mln) -8 -28 -73 -112 -143 -81
EBIT Δ r/r 0.0% 250.4% 160.2% 54.2% 27.5% -43.4%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% -107.3%
Koszty finansowe (mln) 0 0 0 4 0 0
EBITDA (mln) -8 -27 -73 -113 -137 -81
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% -107.3%
Podatek (mln) 0 0 -2 -4 0 3
Zysk Netto (mln) -8 -36 -72 -105 -135 -73
Zysk netto Δ r/r 0.0% 349.9% 99.5% 45.4% 29.4% -46.3%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% -96.1%
EPS -0.18 -0.82 -1.55 -2.22 -2.63 -0.98
EPS (rozwodnione) -0.18 -0.82 -1.55 -2.22 -2.63 -0.98
Ilośc akcji (mln) 44 44 47 47 51 74
Ważona ilośc akcji (mln) 44 44 47 47 51 74
Waluta USD USD USD USD USD USD